Bio-Rad Laboratories Inc. (NYSE: BIO): Jefferies maintained a Buy rating with a $615 target price. The consensus target is $616.80. The shares closed on Thursday at $492.13.
CymaBay Therapeutics Inc. (NASDAQ: CBAY): BTIG Research started coverage with a Buy rating and a $15 target price. The consensus target is $12. The shares closed on Thursday at $9.02.
Etsy Inc. (NYSE: ETSY): Jefferies downgraded the stock to Underperform from Buy. It also chopped its $150 target price to $85, well below the $139.31 consensus target. The shares closed almost 5% lower on Thursday at $107.85 after the double downgrade.
Exact Sciences Corp. (NASDAQ: EXAS): Citigroup lifted its Neutral rating to Buy, and the $70 target price increased to $90. The consensus target is $73.65. The shares closed on Thursday at $66.18.
Fortune Brands Innovations Inc. (NYSE: FBIN): Credit Suisse downgraded the shares to Underperform from Neutral and has a $48 target price. The consensus target is $68.07. Thursday’s final trade was reported at $60.65.
Guardant Health Inc. (NASDAQ: GH): Citigroup’s downgrade from Buy to Neutral included a target price cut from $60 all the way to $33. The consensus target is $57.63. Thursday’s $27.67 close was down over 4% for the day on the downgrade.
Hilton Worldwide Holdings Inc. (NYSE: HLT): Barclays upgraded the stock to Overweight from Equal Weight. It also boosted its $151 target price to $168, while the consensus target is $148.18. The last trade on Thursday was reported at $145.38.
Hyatt Hotels Corp. (NYSE: H): Barclays downgraded the shares to Equal Weight from Overweight and trimmed its $130 target price to $125. The consensus target is $123.16. The stock ended Thursday trading at $114.63.
Life Time Group Holdings Inc. (NYSE: LTH): Oppenheimer reiterated an Outperform rating and has a $33 target price. The consensus target is just $19.70. The stock closed on Thursday at $17.45.
Meta Platforms Inc. (NASDAQ: META): Oppenheimer reiterated an Outperform rating on the Facebook and Instagram parent and raised its $220 target price to $235. The consensus target is $208.74. Thursday’s close was at $181.36.
MongoDB Inc. (NASDAQ: MDB): Goldman Sachs lowered its $325 price target to $280 but maintained a Buy rating. The consensus target is $258.66 for now. The shares closed on Thursday at $207.73, down almost 10% on the day despite a fourth-quarter earnings beat.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
